Cargando…

A randomised study comparing intermittent to continuous administration of magnesium aspartate hydrochloride in cisplatin-induced hypomagnesaemia.

Detalles Bibliográficos
Autores principales:	Vokes, E. E., Mick, R., Vogelzang, N. J., Geiser, R., Douglas, F.
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 1990
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1971562/ https://www.ncbi.nlm.nih.gov/pubmed/2257205

Ejemplares similares

Hypomagnesaemia and Magnesium Deficiency
por: Sutton, R. A. L.
Publicado: (1968)

Posaconazole and isavuconazole induced hypomagnesaemia
por: Burston, John, et al.
Publicado: (2018)

Hypomagnesaemia – One Cause To Remember!
por: Viegas, Ana Filipa, et al.
Publicado: (2022)

Thermodynamics of binding of divalent magnesium and manganese to uridine phosphates: implications for diabetes-related hypomagnesaemia and carbohydrate biocatalysis
por: Zea, Corbin J, et al.
Publicado: (2008)

Oral magnesium supplementation improves glycemic control and lipid profile in children with type 1 diabetes and hypomagnesaemia
por: Shahbah, Doaaa, et al.
Publicado: (2017)

Severe hypomagnesaemia with tetany following ESHAP protocol
por: Majumdar, Gautam
Publicado: (2002)

Familial hypomagnesaemia with hypercalciuria and nephrocalcinosis: clinical and molecular characteristics
por: Claverie-Martin, Felix
Publicado: (2015)

Proton-Pump Inhibitors and Hypomagnesaemia in Kidney Transplant Recipients
por: Douwes, Rianne M., et al.
Publicado: (2019)

Co-Administration of Fendiline Hydrochloride Enhances Chemotherapeutic Efficacy of Cisplatin in Neuroblastoma Treatment
por: Brizzolara, Antonella, et al.
Publicado: (2020)

Hypomagnesaemia As a Mortality Risk Factor in Protein-energy Malnutrition
por: Karakelleoglu, Cahit, et al.
Publicado: (2011)

Hypomagnesaemia associated with long-term use of proton pump inhibitors
por: Toh, James Wei Tatt, et al.
Publicado: (2015)

Case Report: Investigation and molecular genetic diagnosis of familial hypomagnesaemia
por: Willows, Jamie, et al.
Publicado: (2019)

Hydrochlorothiazide: Refractory hypokalaemia and hypomagnesaemia in an elderly patient: case report
Publicado: (2013)

Hypomagnesaemia and other electrolytes imbalances in open and closed pediatrics cardiac surgery
por: Shahidi, Mohsen, et al.
Publicado: (2019)

Hypomagnesaemia induced recurrent cerebellar ataxia: an interesting case with successful management
por: Kumar, Singh Saraj, et al.
Publicado: (2020)

Severe hypomagnesaemia as new potential stroke mimic: a case report
por: Gardin, Anna, et al.
Publicado: (2022)

Antitumour activity and plasma kinetics of bleomycin by continuous and intermittent administration.
por: Peng, Y. M., et al.
Publicado: (1980)

De novo HNF1 homeobox B mutation as a cause for chronic, treatment-resistant hypomagnesaemia
por: Stiles, C E, et al.
Publicado: (2018)

Prevalence and predictive factors of preoperative hypomagnesaemia among adult surgical patients in a large tertiary hospital in Ghana
por: Djagbletey, R., et al.
Publicado: (2015)

Is hypomagnesaemia a coronary risk factor among Indians with coronary artery disease?
por: Mahalle, Namita, et al.
Publicado: (2012)

The Perilous PPI: Proton Pump Inhibitor as a Cause of Clinically Significant Hypomagnesaemia
por: Tai, Yong Ting, et al.
Publicado: (2020)

Hypermagnesaemia, but Not Hypomagnesaemia, Is a Predictor of Inpatient Mortality in Critically Ill Children with Sepsis
por: Wang, Huabin, et al.
Publicado: (2022)

Possible role for rare TRPM7 variants in patients with hypomagnesaemia with secondary hypocalcaemia
por: Vargas-Poussou, Rosa, et al.
Publicado: (2022)

Therapy with teicoplanin in the ICU: continuous intravenous infusion or intermittent intravenous administration?
por: Nardi, E, et al.
Publicado: (2008)

Clinical and microbiological efficacy of continuous versus intermittent administration of vancomycin in critical care patients
por: Štepán, M, et al.
Publicado: (2009)

Hypomagnesaemia and its determinants in a contemporary primary care cohort of persons with type 2 diabetes
por: Waanders, Femke, et al.
Publicado: (2019)

Does long-term use of proton pump inhibitors cause hypomagnesaemia in Japanese outpatients?
por: Takeda, Yasuhito, et al.
Publicado: (2015)

Two novel mutations of the CLDN16 gene cause familial hypomagnesaemia with hypercalciuria and nephrocalcinosis
por: Hanssen, Oriane, et al.
Publicado: (2014)

The Prevalence of Hypomagnesaemia in Pediatric Patients with Mitral Valve Prolapse Syndrome and the Effect of Mg Therapy
por: Amoozgar, Hamid, et al.
Publicado: (2012)

Intravenous Administration of Cisplatin with Magnesium Sulfate Supplement May Prevent Kidney Toxicity in Rats: The Role of Gender and Magnesium Sulfate Dose
por: Pournaderi, Parisa, et al.
Publicado: (2022)

Continuous versus intermittent methylene blue administration: which spin will win?
por: Senthilkumaran, Subramanian, et al.
Publicado: (2014)

A novel CLDN16 mutation in a large family with familial hypomagnesaemia with hypercalciuria and nephrocalcinosis
por: Deeb, Asma, et al.
Publicado: (2013)

'Lemonade Legs': Why do Some Patients Get Profound Hypomagnesaemia on Proton-Pump Inhibitors?
por: Atkinson, Nathan S. S., et al.
Publicado: (2015)

Cyclin M2 (CNNM2) knockout mice show mild hypomagnesaemia and developmental defects
por: Franken, Gijs A. C., et al.
Publicado: (2021)

Continuous Eructations Treated by Emetine Hydrochloride
por: Kothary, K. L.
Publicado: (1942)

Effect of Oral Administration of Magnesium on Cisplatin-Induced Nephrotoxicity in Normal and Streptozocin-Induced Diabetic Rats
por: Soltani, Nepton, et al.
Publicado: (2013)

Familial hypomagnesaemia with hypercalciuria and nephrocalcinosis (FHHNC): Compound heterozygous mutation in the claudin 16 (CLDN16) gene
por: Hampson, Geeta, et al.
Publicado: (2008)

Omeprazole- and Esomeprazole-associated Hypomagnesaemia: Data Mining of the Public Version of the FDA Adverse Event Reporting System
por: Tamura, Takao, et al.
Publicado: (2012)

Meropenem administration by intermittent infusion versus continuous infusion for the treatment of nosocomial pneumonia
por: Lorente, L, et al.
Publicado: (2005)

A Patient on Long-Term Proton Pump Inhibitors Develops Sudden Seizures and Encephalopathy: An Unusual Presentation of Hypomagnesaemia
por: Gandhi, Nirav Y., et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_n6g1j2edukn38359345kthfaen